COMPANY

TAKEDA CANADA INC

TAKEDA CANADA INC: marketing authorisation holder for Icatibant, Teduglutide, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

IcatibantFIRAZYR (DIN 02425696), Marketed Regulator Health Canada
TeduglutideREVESTIVE (DIN 02445727), Marketed Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.